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Mammalian cells respond to virus infection or other viral stresses, such as double-stranded (ds) RNA and interferons (IFN), by robust and
rapid induction of viral stress-inducible proteins. The induction and actions of one such protein, the human P56, have been extensively
studied. However, little is known about the distantly related mouse proteins, MuP56 and MuP54. Here, we report that, in mouse cells, they
could be induced by IFN, dsRNA or Sendai virus infection. MuP56 and MuP54 inhibited protein synthesis in vitro by binding to the ‘‘c’’, but
not the ‘‘e’’, subunit of the translation initiation factor, eIF-3. The N-terminal region of the MuP54 was sufficient for inhibiting translation, but
it and the corresponding region of MuP56 bound to two different regions of eIF3c. Thus, members of the human and murine P56 family have
similar but non-identical functions.
D 2005 Elsevier Inc. All rights reserved.Keywords: Interferon; Double-stranded RNA; Sendai virus; Viral stress-inducible genes; Interferon-stimulated genes; Translational regulation; Eukaryotic
initiation factor-3Introduction
Cells respond to virus infection in a variety of ways, one
of which is by inducing transcription of cellular genes that
are usually silent in uninfected cells (Sarkar and Sen, 2004).
Induction of these viral stress-inducible genes (VSIG) can
be mediated by a number of signaling pathways depending
on the nature of the inducer (Sen and Sarkar, 2005). The
inducer can be the infecting virions themselves (Zhu et al.,
1998; Chang and Laimins, 2000; Johnston et al., 2001;
Mossman et al., 2001), subviral particles derived from them
(Boyle et al., 1999), viral gene products such as double-
stranded (ds) RNA (Geiss et al., 2001) or single-stranded
(ss) RNA (Lund et al., 2004) or virally induced cellular
cytokines such as type I interferon (IFN) (Der et al., 1998;
Geiss et al., 2003). Extensive analyses of human VSIG
induction pathways have revealed that a large subset of0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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E-mail address: seng@ccf.org (G.C. Sen).these genes is induced through the interferon-stimulated
response elements (ISRE) present in their promoters (Levy
et al., 1968; Reich et al., 1987; Cohen et al., 1988; Porter et
al., 1988; Pellegrini and Schindler, 1993; Bandyopadhyay et
al., 1995). These elements bind members of the interferon-
regulatory factor (IRF) family to promote transcription. IRF-
3 and IRF-7 are the major members that get activated by
various viral stresses, translocate from the cytoplasm to the
nucleus and activate transcription of the target genes
(Servant et al., 2002; Peters et al., 2002; Sato et al., 2000,
Grandvaux et al., 2002). IFN, on the other hand, induces the
same genes using the same cis-element, ISRE, but a
different transcription factor, ISGF-3, that is composed of
IRF-9, STAT1 and STAT2 (Darnell et al., 1994; Stark et al.,
1998; Levy and Darnell, 2002). While the activation
mechanism of ISGF-3 by IFN, using the Jak/STAT path-
ways, is well understood, the pathways used by various viral
stresses to activate IRF-3 are still being delineated (Sharma
et al., 2003). Among the major advances made recently in
this endeavor is the identification of the key protein kinase,
TBK-1, that phosphorylates IRF-3 (Fitzgerald et al., 2003;05) 116 – 124
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receptor (TLR) 3 (Alexopoulou et al., 2001) and the soluble
receptors, RIG-I and mDa 5 (Yoneyama et al., 2004;
Andrejeva et al., 2004) of dsRNA, the adaptor protein
TRIF (Yamamoto et al., 2002) and the membrane-receptor
of single-stranded RNA, TLR7 and TLR8. Which of these
proteins are used for activating IRF-3 depends on the
specific virus and the host cell. Among the human VSIGs,
the most prominent ones are the members of the ISG56
family (Der et al., 1998; Geiss et al., 2001). These genes are
not expressed or expressed at a low level in most human cell
lines, but they are induced to high levels upon infection with
many viruses and treatment with IFN or dsRNA (Guo et al.,
2000a). Human P56 interacts with the Fe_ subunit of the
eukaryotic translation initiation factor eIF3 (Guo et al.,
2000b) and selectively inhibits its ability to stabilize the
ternary complex of eIF-2, GTP and Met-tRNAi (Hui et al.,
2003). As a result, human P56 inhibits initiation of
translation. In human cells infected with hepatitis C virus,
ISG56 is induced, and the encoded P56 protein is associated
with ribosomes bound to HCV RNA, presumably causing a
block in Hep C protein synthesis (Wang et al., 2003). The
P56 family of proteins contains multiple tetratricopeptide
repeat (TPR) motifs, which mediate protein–protein inter-
actions (Sarkar and Sen, 2004). The interaction of human
P56 with eIF3e is thought to be mediated by the PCI (named
for proteasome, COP9/signalosome and initiation factor)
(Hoffman and Bucher, 1998) motif of the latter protein (Guo
et al., 2000b).
Little is known about the induction pattern of the P56
family of proteins in mouse. Recently, we have reported that
the mouse p56 protein can also inhibit protein synthesis
(Hui et al., 2005). But, in contrast to human P56, it interacts
with, not the Fe_, but the Fc_ subunit of eIF3, thus
underscoring key differences in the properties of human
and mouse proteins. Here, we report the characteristics of
induction of mouse P56 and mouse P54, in vitro, in
response to dsRNA treatment and Sendai virus (SeV)
infection. We also report that both proteins inhibit trans-
lation by interacting with eIF3c, but their interaction
patterns are different, suggesting similar but not identical
functions. The results reported here provide the groundwork
for this important group of proteins in mouse, and the
information provided by this study is essential for assessing
their roles in mediating host response to infection by various
viruses in a variety of mouse models.Fig. 1. Comparison of human and murine viral stress-inducible P56 protein
family members. (A) Homology of protein sequences between family
members is shown with dot-plot matrix using MacVector according to the
following parameters: pam 250 matrix; window size 8; min % score 60. (B)
Structural similarity among protein family members is shown by
distribution of TPR domains (shaded ovals) according to the InterPro
protein database.Results
Comparisons of primary structures
Because human P56 and P54 have previously been
identified as major viral stress-inducible proteins, we started
an investigation of the corresponding mouse proteins,
MuP56 and MuP54. MuP56 has only 53% sequencehomology to HuP56, and the sequence is conserved mostly
in the N-terminal half of the proteins (Fig. 1A). Similarly,
MuP54 and HuP54 have only 62.8% sequence homology.
There are even less sequence conservations between MuP56
and MuP54 as well as HuP56 and HuP54 (Fig. 1A). The
only identified structural motifs present in HuP56 are six
TPR motifs; MuP56 also has those six motifs (Fig. 1B). It is
remarkable that these motifs are located at similar positions
on the proteins, although their C-terminal halves have little
sequence homologies. Both P54 proteins contain only four
TPR motifs, all in the N-terminal parts of the proteins. The
locations of the first TPRs are different in MuP54 and
HuP54, but the other three are located in identical places.
These analyses show that the TPR motifs, but not the overall
sequences, are highly conserved between MuP56 and
HuP56 and between MuP54 and HuP54.
Induction by IFN and dsRNA
Steady-state levels of the mRNAs for the murine genes
encoding MuP56 and MuP54 were measured in primary
mouse cells using quantitative RNase protection assays. In
bone-marrow-derived macrophages (BMDM), there was no
basal expression, but both mRNAs were strongly induced
by either dsRNA or IFN-h (Fig. 2A). In contrast, in mouse
embryo fibroblasts, only IFN-h could induce them (Fig.
2B). These results show that the MuP56 and the MuP54
genes can be induced by one agent, but not another, in
different cell types. The observed differences could be
Fig. 2. Induction of MuP54 and MuP56 mRNAs. RNase protection assays
for MuP54 and MuP56 mRNAs are shown. (A) Bone-marrow-derived
macrophages and (B) MEF cells were stimulated for 6 h with dsRNA (100
Ag/ml) or mouse IFN-h (1000 U/ml) and RNAwas extracted for RPA assay.
Cyclophilin mRNA levels were used as internal controls.
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both BMDM and MEF, whereas the dsRNA-receptor,
TLR3, is expressed only in BMDM, but not in MEF.
To be able to examine the induction characteristics of the
corresponding proteins, we attempted to raise anti-peptide
antibodies for the two proteins. This was successful for
MuP56, but not for MuP54. In Western blot analysis, the
MuP56 antiserum recognized MuP56, expressed in cells by
transfections, and the recognition was completely competed
out by the peptide used for raising the antibody (Fig. 3A). In
MEF, IFN-h induced MuP56 protein quite strongly (Fig.
3B), but as expected (Fig. 2B), dsRNA, when added to the
culture medium, failed to induce MuP56 (Fig. 3C). But
when dsRNAwas transfected, MuP56 was strongly induced
in MEF (Fig. 3C), demonstrating that activation of the
internal RIG-I system by dsRNA leads to induction ofFig. 3. Expression of MuP56 protein. (A) HT1080 cells were transfected
with an expression vector of MuP56. 50 Ag of cell lysate was used for
Western blot with anti-MuP56 polyclonal antibody. The specificity of the
antibody is shown by blocking with the peptide against which the antibody
was raised. (B) Similar Western blots were performed with 60 Ag cell lysate
from MEF treated with IFN-h (1000 U/ml) for 16 h. (C) MEF cells were
transfected with Fugene 6 alone or with Fugene 6 and dsRNA or treated
with dsRNA added to the medium for 16 h, and Western blot was
performed on total cell lysates. (D) BMDM treated with dsRNA (100 Ag/
ml) or IFN-h (1000 U/ml) for the indicated time periods.MuP56 as well. In BMDM, as expected, both dsRNA and
IFN-h could induce the protein, and the induction level
peaked around 8 h (Fig. 3D).
Induction by Sendai virus infection
To examine whether MuP56 can be induced by virus
infection, we infected mouse L929 cells with SeV. MuP56
was induced within 8 h after infection, and it was present in
cells even 48 hpi (Fig. 4A) Similarly in MEF, SeV infection
or IFN-h treatment induced the protein strongly (Fig. 4B).
To test whether the induction by SeV is mediated by
intermediate production of IFN, we used Stat1/ MEF.
These cells cannot respond to any type of IFN because Stat1
is required for signaling by IFN-a, IFN-h and IFN-g. In
these cells, as expected, IFN-h could not induce MuP56 but
SeV could, although with a slower kinetics (Fig. 4C). These
results demonstrated that SeV infection could induce
MuP56 directly. By inactivating the viral RNA genome
using UV exposure of the virions, we investigated whether
viral gene expression was required for MuP56 induction.
UV-inactivated virus was equally capable of inducing
MuP56 in mouse cells (Fig. 4D), suggesting that the
infecting virions or subviral particles derived from them
are capable of inducing these viral stress-inducible proteins.
Inhibition of translation by MuP54 and MuP56
In the next series of experiments, we investigated the
functions of MuP54 and MuP56. For this purpose, the
proteins were expressed in E. coli as hexahistidine-tagged
proteins, and the recombinant proteins were purified by Ni-
agarose chromatography (Fig. 5A). The abilities of the twoFig. 4. Sendai virus induces MuP56 protein. Western blots of protein using
anti-MuP56 polyclonal antibody are shown. (A) L929 cells were infected
with SeV (80 HAU/ml) for the indicated time period, (B) WT MEF cells or
(C) Stat1/ MEF cells were treated with IFN-h (1000 U/ml) or infected
with SeV for the time indicated in the figure. (D) WT MEF cells were mock
infected, infected for 6 h with SeV or with SeV that had been UV-
inactivated for 60 s.
Fig. 5. Recombinant MuP54 inhibits translation. (A) Purified His-tagged
MuP56 and His-tagged MuP54 were detected by Coomassie blue staining.
(B) Luciferase mRNA was translated using a rabbit reticulocyte lysate
system containing [35S]cysteine in the presence of dialysis buffer or 0.9 AM
purified MuP54, MuP56 or HuP56. Translated luciferase was analyzed by
SDS-PAGE and quantitated using Molecular Diagnostic Phosphoimager.
Inhibition is shown as a percentage of the dialysis buffer control (100%
translation). (C) Different concentrations of purified MuP54 were tested for
translation inhibition. Experiments were performed in triplicates.
Fig. 6. MuP56 and MuP54 interact with eIF3c, but not with eIF3e. (A and
B) show in vitro binding experiments. 18 pmol His-MuP54 protein was
incubated with 18 pmol of (A) purified eIF3 or (B) purified eIF3c. After
incubations, the samples were pulled down with Ni+ beads, and the bound
proteins were analyzed by Western blotting with antibody against (A) eIF3
or (B) flag. (C) and (D) show in vivo experiments. Expression vectors for
(C) flag-tagged eIF3e or (D) flag-tagged eIF3c were co-transfected into
HT1080 cells with expression vectors of myc-tagged MuP56 or MuP54, as
indicated. Cell extracts were made, and immunoprecipitations (IP) were
performed with Flag antibody-conjugated agarose beads followed by
Western blot (wb) with anti-Myc or anti-Flag antibody, as indicated. Cell
lysates (60 Ag) were also directly subjected to Western blotting (wb) with
anti-Flag or anti-Myc antibody.
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using an in vitro reticulocytes lysate system. Both of them
inhibited translation almost as strongly as HuP56 (Fig. 5B).
The inhibition by MuP54 was dose-dependent, and, at the
highest doses tested, protein synthesis was reduced by
almost 90% (Fig. 5C).
Interaction with eIF3c
HuP56 blocks initiation of protein synthesis by binding
to the ‘‘e’’ subunit of the translation initiation factor eIF3
(Hui et al., 2003). The interaction between the two proteins
can be detected by co-immunoprecipitation of epitope-
tagged proteins expressed in mammalian cells. Using this
assay, no interaction could be detected between MuP54 and
eIF3e, although both proteins were expressed efficiently in
the transfected cells (Fig. 6C). However, in the same
experiment, as expected, a strong interaction was manifested
between HuP56 and eIF3e. In contrast, MuP54 interacted
with a different subunit of eIF3, eIF3c, as did MuP56 (Fig.
6D). Similarly, purified recombinant MuP54 interacted withthe ‘‘c’’ subunit of purified eIF3 complex (Fig. 6A) and with
purified eIF3c (Fig. 6B). Thus, both mouse proteins interact
with an eIF3 subunit that is different from the one that
interacts with human P56.
In the next series of experiments, we mapped the
domains of MuP56 and MuP54 that interact with eIF3c.
For this purpose, for both proteins, increasing deletion
mutants from the C-terminal were expressed in cells, and
their interactions with eIF3c were monitored by their co-
immunoprecipitations. Wt MuP56 and four deletion mutants
were efficiently expressed, and they all interacted with
eIF3c (Fig. 7A). Similarly, wt MuP54 and its three deletions
mutants could all interact with eIF3c (Fig. 7B). These results
demonstrated that N-terminal domains of MuP56, contain-
Fig. 7. Mapping the domains of MuP54 and MuP56 that interact with eIF3c.
4 Ag of plasmids expressing full length (wt) or different N-terminal domains
(d) of (A) myc-MuP56 or (B) myc-MuP54 was co-transfected with 4 Ag of
an expression vector of flag-eIF3c in HT1080 cells. Protein extracts were
used for immunoprecipitation with Flag antibody-conjugate agarose beads
followed by Western blotting with antibody against Myc peptide in upper
panels (A and B). Same protein extracts were also analyzed by direct
immunoblotting using monoclonal antibody against Flag, middle panels (A
and B), or Myc, lower panels (A and B). d1* (MuP56 containing 1–140 aa),
d2* (MuP56 containing 1–241 aa), d3* (MuP56 containing 1–299 aa) and
d4* (MuP56 containing 1–365 aa), d1 (MuP54 containing 1–127 aa), d2
(MuP54 containing 1–171 aa), d3 (MuP54 containing 1–208 aa). (C) The
minimal regions of MuP56 or MuP54 sufficient to bind to eIF3c are
schematized.
Fig. 8. MuP54 and MuP56 bind to different regions of eIF3c. HT1080 cells
were co-transfected with 4 Ag of vectors expressing full-length flag-eIF3c
or a deletion mutant containing residues 1–656 aa (flag-eIF3c*) and 4 Ag
of (A) myc-MuP56 or (B) myc-MuP54. Protein extracts were used for
immunoprecipitation using the Flag antibody-conjugate agarose beads and
precipitated protein analyzed by immunoblot with antibody against Myc or
Flag as indicated. Same protein extracts were used for direct immunoblot
with anti-Flag antibody or anti-Myc antibody. (C) The interacting domains
of MuP56, MuP54 and eIF3c are shown. The N-terminal 1–140 residues of
MuP56 containing TPR1 and TPR2 (the boxes) interact with the N-terminal
(1–656) region of eIF3c, whereas the N-terminal (1–127) region of MuP54
containing TPR1 (the box) probably interacts with the C-terminal (656–
913) domain of eIF3c.
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are sufficient for binding to eIF3c (Fig. 7C). To map the
regions of eIF3c that interact with MuP56 and MuP54, we
generated eIF3c*, a C-terminal deletion mutant of eIF3c.
This mutant interacted with MuP56 (Fig. 8A), but not with
MuP54 (Fig. 8B), although the wt protein interacted with
both. These results suggest that the N-terminal of MuP54
interacts with the C-terminal region of eIF3c, whereas the
N-terminal region of MuP56 interacts with the N-terminal
region of eIF3c (Fig. 8C).
To test the functional capacity of the N-terminal domain
of MuP54, a truncated protein (d1) containing only residues
1–127 aa was expressed in bacteria and purified by affinity
chromatography (Fig. 9A). As expected, MuP54-d1 inter-
acted with purified eIF3 (Fig. 9B) and with purified eIF3c
(Fig. 9C). It also inhibited translation in vitro in a dose-
dependent fashion (Fig. 9D). Even though the truncatedprotein, d1, was about 8-fold less active, as compared to the
full-length protein, at the highest dose tested (60 AM), it
inhibited protein synthesis by more than 90%. Thus, the
observed physiological interaction between d1 and eIF3
resulted in a strong inhibition of eIF3 function.Discussion
The mouse ISG56 family has three members, ISG56,
ISG54 and ISG49 encoding proteins of calculated molecular
masses of 53.7 kDa, 55.0 kDa and 47.2 kDa. Phylogenetic
analysis shows that MuP56 protein is most closely related to
HuP56, MuP54 to HuP54 and MuP49 to HuP60 (Sarkar and
Sen, 2004). The MuISG56 and MuISG54 genes have
similar organizations, and both are induced by IFN-a
(Bluyssen et al., 1994). The promoter of MuISG54 has
one authentic IFN-stimulated response element (ISRE),
whereas the MuISG56 promoter has two such elements.
Since these elements can be recognized by many members
of the IRF family of transcription factors, a variety of viral
stresses that activate different signaling pathways leading to
IRF activation may be able to induce transcription of these
genes. The relevant mediators of viral stress include type I
IFNs, dsRNA and viral ribonucleoproteins.
As expected, both MuP56 and MuP54 mRNAs were
induced in BMDM and MEF by IFN-h. They were also
induced by dsRNA in BMDM, but not in MEF cells (Fig. 2).
Because BMDM, but not MEF cells, express TLR3, a known
Fig. 9. Recombinant d1, a deletion mutant of MuP54, inhibits translation.
(A) His-tagged MuP54 or His-tagged d1 was purified using Ni-affinity
chromatography and detected by Coomassie blue staining. 18 pmol His-d1
protein were incubated with 18 pmol of (B) purified eIF3 or (C) flag-
peptide purified eIF3c. After incubation, the samples were pull down with
Ni+ beads, and the retained proteins were eluted, samples were analyzed by
Western blotting with antibody against (B) eIF3 or (C) flag. (D) Luciferase
mRNA was translated using a rabbit reticulocyte lysate system containing
[35S]cysteine in the presence of dialysis buffer (lane 1) and increasing
amounts of MuP54 (2.6, 5.2 and 7.8 AM), lanes 2–4 or d1 (20, 40 and 60
AM), lanes 5–7. Translated luciferase was analyzed by SDS-PAGE and
quantitated using Molecular Diagnostic Phosphoimager. Inhibition is shown
as a percentage of the dialysis buffer control (100% translation). Data are
presented as averages of three experiments.
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these genes by dsRNA was most probably mediated by
TLR3. Activation of the intracellular RIG-I pathway by
transfection of MEF with dsRNA also caused activation of
the MuP56 gene. For MuP56, an antibody was raised, and
we confirmed induction of the protein in MEF by IFN-h and
in BMDM by dsRNA and IFN-h (Fig. 3). The protein was
detected as early as 4 h and was present in abundant quantity
even 24 h after dsRNA treatment. This is the first
demonstration of induction of MuP56 because no antibody
was previously available. A third agent, SeV, also induced
the protein efficiently (Fig. 4). Viral induction of the protein
did not require viral gene expression because UV-inactivated
SeV was equally effective (Collins et al., 2004). Because
viral induction of MuP56 was observed in STAT1/MEF, itdoes not require the action of IFN as an intermediate.
However, the induction was quicker and more robust in Wt
cells (compare Figs. 4B and C), indicating that both IFN-
dependent and independent pathways may contribute to full
induction of this protein in response to SeV infection. The
viral induction does not require TLR3 because MEFs, which
do not express TLR3, responded to SeV but not to dsRNA.
This observation is consistent with our recent observation of
TLR3-independent induction of HuP56 in response to SeV
infection (Elco et al., 2005).
The second part of this study was devoted to
examining the function of MuP56 and MuP54. For
designing these experiments, we used our experience
with HuP56 (Guo et al., 2000b). Like HuP56, recombi-
nant MuP56 and MuP54 inhibited translation in vitro,
and on a molar basis, the three proteins were similarly
effective (Fig. 5). Although all three proteins interacted
with the translation initiation factor eIF3, the interaction
was mediated through different subunits. While HuP56
interacted with eIF3e, both murine proteins interacted
with eIF3c but not with eIF3e (Fig. 6). This reciprocal
specificity was unexpected especially between HuP56 and
MuP56 because of their similarity in sequence and in the
distribution of TPR motif (Fig. 1). The eIF3c-interaction
domains of MuP56 and MuP54 were mapped to the N-
terminal one-third of the proteins. For MuP56, this region
(d1*) contains two TPR motifs, whereas for MuP54, this
region (d1) contains only one TPR motif (Fig. 7C).
Although both interacted with eIF3c, the sequence
conservation between these regions of the two proteins
is not high (Fig. 1A). The difference in their sequences
was reflected in the functional disparity of their inter-
actions with eIF3c: MuP56 interacted with the N-terminal
region of eIF3c, whereas MuP54 did not.
The eIF3c-interacting region of MuP54 (d1) was
expressed in E. coli and purified to homogeneity. Unfortu-
nately, the corresponding domain of MuP56 (d1*) could not
be expressed in a soluble form. As expected, d1 could
inhibit translation in vitro, thus functionally validating our
interaction domain mapping results. On a molar basis, d1
was about 8 times less effective than the full-length MuP54.
This difference could be due to weaker binding of d1 to
eIF3c or less efficient folding of recombinant d1. We have
recently reported that MuP56 inhibits a distinct function
eIF3, namely, its ability to promote formation of an
initiation complex of 40s ribosome subunit, mRNA and
the eIF2IGTPItRNAi
Met ternary complex (Hui et al., 2005).
In contrast, HuP56 inhibits a different function of eIF3 in
stabilizing formation of the ternary complex (Hui et al.,
2003). The specific function of eIF3 impaired by MuP54
has not been identified yet. Our observation that MuP56 and
MuP54 bind to different regions of eIF3c suggests that they
may inhibit different functions of eIF3 (Hershey and
Merrick, 2000; Benne and Hershey, 1976; Merrick et al.,
1973; Chaudhuri et al., 1999; Gupta et al., 1990; Imataka
and Sonenberg, 1997; Lamphear et al., 1995) which, in turn,
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degrees.
Although the human P56 family of proteins is new and
widely recognized as the premier marker of viral stresses, the
corresponding mouse proteins have not been studied before.
Thus, this report provides the first characterization of mouse
P56 and P54 induction and functions and describes assays
and reagents that will be useful for future studies. For the
mode of induction studies, the mouse system provides the
strength of using knock-out mice and cells for various
receptors and signaling proteins. For the functional aspects,
induction and function of MuP56 and MuP54 in various
mouse models of viral pathogenesis can be studied. The
studies shown here can shed light on the specific functions of
these proteins in vivo, their tissue distributions and cell type
specificity. Similar experiments will be difficult or impossible
to perform in the human system.Materials and methods
Cells, cell treatments and infection
HT1080 human fibrosarcoma (Leonard and Sen, 1997),
L929 murine fibroblast, mouse embryonic fibroblast (MEF)
WTand Stat1/ (Qing and Stark, 2004) were all maintained
in Dulbecco’s modified Eagle’s medium (DMEM) supple-
mented with 10% fetal bovine serum, 100 U/ml penicillin and
100 Ag/ml streptomycin. Primary macrophages derived from
bone marrow (BMMs) were isolated from the femur of FVB
mouse (Whitmore et al., 2004).
HT1080 cells were transfected using Fugene 6 (Boeh-
ringer Mannheim Co.). After 18 h, cells were collected, and
lysates were used for straight Western blotting or for
immunoprecipitation. Murine IFN-h 1000 U/ml (Calbio-
chem) and dsRNA [poly(I)–poly(C)] 100 Ag/ml (Pharmacia)
were added to the culture medium, and the cells were treated
for the desired time periods as indicate in the figures. MEF
cells were transfected with Fugene 6 alone or with Fugene 6
and dsRNA (2 Ag/ml). After 16 h, cells were lysed, and
Western blots were performed using polyclonal antibody
against MuP56. Cells (1  106) were infected with Sendai
virus (Sendai/Cantell, ATCC VR-907) at 80 HAU/ml for 1 h
in serum-free DMEM. Medium was removed, and the cells
were washed then reefed with DMEM which contained 10%
serum and incubated at the time periods indicated in the
figures. UV treatment of virus was performed according to a
reported protocol (TenOever et al., 2002).
Antibody
Polyclonal antibody, anti-MuP56, was raised by Biosyn-
thesis Incorporated, Lewisville, TX, against a peptide
encoding amino acids 217–233 of MuP56 protein. Serum
from injected rabbits was collected and tested for their anti-
MuP56 activity by Western blot. The antibody specificitywas studied by competing with excess of antigen. Briefly, 1
Al of antibody was first incubated with different concen-
trations of peptide (as indicated in the figures) for 2 h at 37
-C, then 16 h at 4 -C. The tubes were centrifuged for 15 min
at 14,000 rpm at 4 -C, and the supernatant was used for
Western blotting.
Constructs
The full-length of eIF3c was constructed by RT-PCR, the
cDNA sequences were inserted into pFLAG-CMV-2
(Kodak Scientific Imaging System) containing Flag on the
N-terminal domain. MuP56 full length was generated by
PCR using an existing clone (our unpublished data), the
cDNA sequence was subcloned in Myc-pcDNA3. This
vector was generated inserting six repeat of 30 nt of the
c-myc peptide in the N-terminal domain of pcDNA3
expression vector. MuP54 or MuP56 deletion mutants were
generated by PCR and subcloned into Myc-pcDNA3. The
full-length eIF3e was described previously (Guo et al.,
2000b). The myc-MuP54 plasmid was a generous gift from
Dr. David E. Levy.
RNase protection assay
RNA was isolated using RNAzol B reagent according to
the manufacturer’s protocol (Teltest, Friendswood, TX).
RNase protection assays (RPAs) were performed with the
RPA III kit (Ambion, Austin, TX) following the manufac-
turer’s protocol. The antisense probes to MuP56 and MuP54
were generated first by cutting the cDNAs with MboII and
StuI, respectively, and then transcribing both with SP6 RNA
polymerase. For each sample, 20 Ag of total RNA was used
for RPA, protected mRNA levels were visualized by
autoradiography.
In vitro translation inhibition assay
A 0.5 Ag aliquot of luciferase mRNA (Promega) was
added to 25 Al reaction of a rabbit reticulocyte lysate in vitro
translation reaction (Promega) in the presence of recombi-
nant purified protein, as indicated in the figure legend. The
in vitro translations were performed under conditions
recommended by the manufacturer, and the reaction mixture
was incubated at 30 -C for 2 h. Newly synthesized [35S]-
labeled proteins were analyzed by loading 5 Al of reaction
on 10% sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE) and quantified by a phosphorimager
using Molecular Dynamics ImageQuant Software.
Purification of recombinant protein from E. coli
MuP54 and MuP56 were subcloned in pET-15b vector
(Novagen). The proteins were expressed in bacterial strain
BL21-DE3 pLys (Novagen) by induction with 1 mM
isopropyl h-d-thiogalactopyranoside (IPTG) for 12 h at 30
F. Terenzi et al. / Virology 340 (2005) 116–124 123-C. Purification was performed using Ni-affinity chroma-
tography. Briefly, bacteria were collected by centrifugation,
resuspended and sonicated in lysis buffer [500 mM KCl, 20
mM Tris pH 7.9, 0.2% NP40, 10% glycerol, 10 mM
imidazole, 5 mM h-mercaptoethanol and protease inhibitor].
Whole-cell lysate was centrifuged at 15,000  g for 30 min,
and the supernatant was added to Ni-NTA agar beads
(Qiagen); the mixture was incubated at 4 -C for 90 min.
After binding, the resin was centrifuged at 3000  g for 5
min and wash with 10 ml of washing buffer I [500 mM KCl,
20 mM Tris pH 7.9, 10% glycerol, 25 mM imidazole, 5 mM
h-mercaptoethanol, protease inhibitor] and 30 ml of wash-
ing buffer II [500 mM KCl, 20 mM Tris pH 7.9, 10%
glycerol, 35 mM imidazole, 5 mM h-mercaptoethanol,
protease inhibitor]. Bound His-MuP56 or His-MuP54 were
eluted with elution buffer [500 mM KCl, 20 mM Tris pH
7.9, 10% glycerol, 300 mM imidazole, 5 mM h-mercapto-
ethanol, protease inhibitor] and dialyzed against a high
glycerol buffer [150 mM KCl, 20 mM Tris pH 7.9, 50%
glycerol] and stored at 20 -C.
Immunoprecipitation and Western blotting
Immunoprecipitation of Flag-tagged protein was per-
formed in low salt buffer [20 mM Tris pH 7.5, 50 mM KCl,
200 mM NaCl, 1 mM EDTA, 20% glycerol, 0.05% Triton 
100, 0.2 mM phenylmethylsulfonyl fluoride (PMSF)] The
M2 anti-Flag agarose beads (Sigma) were pre-soaked with 3
Ag of bovine serum albumin for 15 min. The cell lysates were
prepared as described (Leonard and Sen, 1996), and 300 Ag of
whole-cell extract was mixed with 500 Al of low salt buffer
and 20 Al of pre-incubated anti-Flag agarose beads at 4 -C
overnight. The immunocomplexes were washed with the low
salt buffer and subjected to denaturating gel electrophoresis
through a 10% SDS-PAGE.Western blot was performed with
a 1:2000 dilution of a polyclonal MuP56 antibody. The
Western blot for flag or myc was performed using respec-
tively 1:2000 dilution of anti-Flag M2 monoclonal antibody
(Kodak Scientific Imaging System) and 1:1000 dilution of
c-myc 9E10 monoclonal antibody (Santa Cruz).Acknowledgments
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